Johnson Marvin 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Johnson Marvin
Director
Transactions
- Sale
Common Stock
2025-01-21$0.54/sh−1,610$869→ 12,490 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on March 10, 2024 to cover tax obligations in connection with the vesting of restricted stock units.